A study published online in the journal Circulation finding that while "a pharmacist-led program known as the Adherence and Intensification of Medications (AIM) accelerates the achievement of target blood pressure (BP) levels in people with diabetes," those who did not participate in the program but "received usual care achieved equally low BPs levels, albeit not as quickly." The study covered 4100 patients with diabetes and hypertension in "a prospective, multisite, cluster randomized pragmatic trial involving 16 primary care teams at five US medical centers." In the AIM program, using "electronic pharmacy prescribing and clinical data systems, clinical pharmacists proactively reached out to patients with uncontrolled hypertension and either poor adherence or no treatment changes in response to high BP." The study found that after 6 months those in the AIM program and the other patients had similar results, though those in the AIM program reached their target blood pressures earlier.
Complete article at Circulation
by
Akshaya Srikanth
Pharm.D Resident
India
Complete article at Circulation
by
Akshaya Srikanth
Pharm.D Resident
India
No comments:
Post a Comment